NEI Research News

A new study reveals how the eye resolves inflammation in the eye disease autoimmune uveitis.

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research.

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).

Series fosters global collaboration and exchange of information among international vision researchers and eye health clinical scientists

Researchers from Wayne State University School of Medicine have identified three non-antibiotic drugs that can protect the eye from severe inflammation during bacterial infection.

Ocular inflammation research from OHSU targets gastrointestinal microbes.

In a new study, the researchers show that immune cells respond to the lens, not just following an acute injury in the eye, but also to long-lasting inflammation.

Findings in mice point to potential therapies for blinding eye disease uveitis and multiple sclerosis

An international coalition of eye researchers used machine learning to develop classification criteria for 25 of the most common types of uveitis, a collection of over 30 diseases characterized by inflammation inside the eye.